Davis Ryman

Affiliations

Neuroscience, AbbVie Inc, North Chicago, IL, USA.

Publications (1)

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.

The Lancet. Neurology

Avec: Günter U Höglinger , Irene Litvan , Nuno Mendonca , Deli Wang , Hui Zheng , Beatrice Rendenbach-Mueller , Hoi-Kei Lon , Ziyi Jin , Nahome Fisseha , Kumar Budur , Michael Gold , Davis Ryman , Hana Florian , Auteur inconnu

Réseau de co-auteurs

Günter U Höglinger 1 collaboration

Irene Litvan 1 collaboration

Nuno Mendonca 1 collaboration

Deli Wang 1 collaboration

Hui Zheng 1 collaboration

Beatrice Rendenbach-Mueller 1 collaboration

Hoi-Kei Lon 1 collaboration

Ziyi Jin 1 collaboration

Nahome Fisseha 1 collaboration

Kumar Budur 1 collaboration

Michael Gold 1 collaboration

Hana Florian 1 collaboration

None None 1 collaboration